Pradaxa was designed as a safe and convenient medication to prevent blood clots and strokes in patients with atrial fibrillation. Since it did not require regular blood testing like Coumadin, it became a popular blood thinner prescribed by doctors in more than 70 countries.
Unfortunately, reports now show that Pradaxa can cause serious and difficult-to-treat internal bleeding and thousands of patients have suffered injury or death from conditions like Pradaxa brain hemorrhage.
For now, Pradaxa remains available in the United States. However, a federal judge recently ruled that those affected can proceed with lawsuits and doctors have expressed concern over prescribing the medication.
Within just six months of the time Pradaxa was released in 2010, the FDA had received more than 500 reports of internal bleeding and deaths from conditions like Pradaxa brain hemorrhage. This was higher than 98% of other drugs on the market.
Now, the FDA has launched an investigation into whether all of the risks of Pradaxa were disclosed prior to approval. According to USA Today, the agency received 3,781 reports of side effects and 542 deaths among Pradaxa users in 2011, the most for any drug that year.
If you or a loved one suffered internal bleeding or a Pradaxa brain hemorrhage after taking the drug, it is important to speak with a lawyer about your legal options and compensation under a new lawsuit. Contact us today.
Reports of injury or death among Pradaxa patients have included internal bleeding in the intestines and kidneys, brain hemorrhaging, as well as heart attacks.
While all blood thinners can cause internal bleeding, others have reversal agents that can be used in an emergency. In March of 2012, the Journal of Neurosurgery detailed a specific case of a patient who died from Pradaxa bleeding, as well as concerns of doctors that, once Pradaxa causes internal bleeding, there is little they can do to stop it.
The Journal for The American Medical Association also warned in September of 2012 that the FDA may have hurried approval of Pradaxa without taking into account critical side effects like internal bleeding.
In the latest study of Pradaxa, released by the University of Pécs in Hungary in September, researchers found that patients taking Pradaxa after a heart condition were 3 times as likely to experience internal bleeding. This led them to suggest that the benefits of the drug were not worth the risks.
Lawyers are currently helping those affected by internal bleeding or Pradaxa brain hemorrhage file lawsuits against the manufacturer, Boehringer Ingelheim. These claims have been consolidated into a special federal court in Illinois due to the number of patients affected.
A lawyer can let you know what compensation is available and how long you have to take action. However, due to the specialized nature of these federal MDL cases, it is important to choose a lawyer qualified for this type of lawsuit who has experience fighting large drug companies.
The Drug Resource Center only recommends law firms that specialize in Pradaxa lawsuits.
For more information on the side effects, warnings and legal action related to the drug Pradaxa, or to speak with a lawyer, contact us today. We are available 24 hours a day to provide help.
Authored by Chris Schroeder